1Tincani A, Balestrieri G,Spatola L,et al. Anticardiolipin and antibeta (2)-glycoprotein I immunoassays in the diagnosis of antiphospholipid syndrome. Clin Exp Rheumatol, 1998, 16: 396-402.
2Loizou S, Singh S, Wypkema E, et al. Anticardiolipin, anti-beta (2)-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis, 2003, 62:1106-1111.
3Guqlielmone H, Vitozzi S, Elbarcha O, et al. Cofactor dependence and isotype distribution of anticardiolipin antibodies in viralinfections. Ann Rheum Dis,2001,60:500-504.
4Sanmarco M, Soler C, Christides C, et al. Prevalence and clinical significance of IgG isotype anti-beta 2-glycoprotein I antibodies in antiphospholipid syndrome : a comparative study with anticardiolipin antibodies. J Lab Clin Med, 1997,129:499-506.
5Pierangeli SS, Goldsmith GH, Krnic S, et al. Differences in functional activity of anticardiolipin antibodies from patients with syphilis and those with antiphospholipid syndrome. Infect Immun, 1994,62:4081-4084.
6Villalta D,Alessio MG, Tampoia M, et al. Accuracy of the First Fully Automated Method for Anti-cardiolipin and Anti-132- Glycoprotein I Antibody Detection for the Diagnosis of Antiphospbolipid Syndrome. Ann N Y Acad Sci,2009,1173:21-27.
8Tincani A, Balestrieri G, Allegri F, et al. Overview on anticardiolipin ELISA standardization. J Autoimmun, 2000, 15 : 195-197.
9Santigao M, Mm'dnclli R, Ko A, et al. Anti-beba2 glycoprotein I and Anticardiolipin antibodies in leptospirosis, syphilis and kalaazar. Clin Exp Rheumatol,2001,19 :425-430.
3Tincani A, Balestrieri G, Allegri F, et al. Overview on anticardiolipin ELISA standardization [ J ]. J Autoimmun ,2000,15 (2) : 195-197.
4Marai I,Gilbund B,Blank M,et al. Anti-eardiolipin and anti-β2-glycoprotein I (β2-GPI) antibody assays as screening for anti-phospholipid syndrome [ J ]. Hum Antibodies,2003,12 ( 1 ) :57-62.
5Levy RA, de Meis E, Pierangeli S. An adapted ELISA method for differentiating pathogenic from nonpathogenic aPL by a beta 2 glycoprotein 1 dependency anticardiolipin assay [ J ]. Thromb Res, 2004,114 (545) :573-577.
7Lopez-Soto A, Cervera R, Font J, et al. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid,phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients. Clin Exp Rheumatol, 1997, 15:143-149.
8Ninomiya C, Taniguchi O, Kato T, et al. Distribution and clinical significance of lupus anticoagulant and anticardiolipin antibody in 349 patients with systemic lupus erythematosus. Intern Med, 1992,31:194-199.
9Sachse C, Luthke K, Hartung K, et al. Significance of antibodies to cardiolipin in unselected patients with systemic lupus erythematosus: clinical and laboratory associations. The SLE Study Group.Rheumatol Int, 1995, 15:23-29.
10Loizou S, Cofiner C, Weetman AP, et al. Immunoglobuliu class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol, 1992, 90:434-439.
